Filing Details

Accession Number:
0001209191-12-019487
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-03-21 22:10:15
Reporting Period:
2012-03-19
Filing Date:
2012-03-21
Accepted Time:
2012-03-21 21:10:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
353569 Quidel Corp QDEL In Vitro & In Vivo Diagnostic Substances (2835) 942573850
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1406652 C Douglas Bryant 10165 Mckellar Court
San Diego CA 92121
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-01-18 5,028 $15.14 193,261 No 4 F Direct
Common Stock Disposition 2012-02-02 9,163 $14.51 184,098 No 4 F Direct
Common Stock Acquisiton 2012-03-19 10,000 $16.55 194,098 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 F Direct
No 4 P Direct
Footnotes
  1. The disposition of shares as set forth above was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon vesting of restricted stock units.
  2. The amount of securities beneficially owned following the reported transaction includes 3,893 shares acquired under the Issuer's Employee Stock Purchase Plan.
  3. The weighted average purchase price for these transactions was $16.54616 per share, with a range of $16.30 to $16.58 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares purchased at each separate price.